Literature DB >> 20056124

Effect of temporally controlled release of dexamethasone on in vivo chondrogenic differentiation of mesenchymal stromal cells.

Soon Eon Bae1, Dong Hoon Choi, Dong Keun Han, Kwideok Park.   

Abstract

Controlled release of biologically active molecules is of importance in regulating stem cell migration and differentiation. The purpose of this study is to investigate the effect of dexamethasone (Dex) released from two different sets of poly(lactic-co-glycolic acid) (PLGA) microspheres on chondrogenic differentiation of mesenchymal stromal cells (MSCs) in vivo. Either nonporous (NPMS) or porous (PMS) Dex-loaded PLGA microspheres were fabricated using double emulsion-solvent evaporation method. Each set of microspheres was combined with a composite hydrogel of hyaluronic acid (HA) and Pluronic F127 along with the addition of rabbit MSCs. These hydrogel constructs were then injected subcutaneously in nude mouse and they were retrieved after 2 and 4 weeks respectively. Each group of microspheres presented significantly different in vitro release profiles of Dex on a temporal basis. The composite hydrogel carried a property of sol-gel transition and thus formed a gel at body temperature. It was interesting that the in vitro cell viability in the hydrogel containing NPMS was found better than the one with PMS. A sign of chondrogenic differentiation from the transplanted samples was identified from semi-quantitative reverse transcription polymerase chain reaction (RT-PCR). The gene expression of the cartilage-specific markers Sox 9 and type II collagen was notably upregulated in the PMS-loaded construct than in the NPMS-loaded one. Alcian blue staining displayed that the amount of cartilage-specific extracellular matrix glycosaminoglycan (GAG) was more visibly pronounced in the PMS group. Immunohistochemical analysis of the retrieved constructs also supported that synthesis of type II collagen was more active with the PMS group. The present work suggested that an in vivo chondrogenic potential of MSCs could be affected by characteristic release profile of chondrogenic factor in vitro. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20056124     DOI: 10.1016/j.jconrel.2009.12.024

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  10 in total

Review 1.  Hydrogels for the repair of articular cartilage defects.

Authors:  Kara L Spiller; Suzanne A Maher; Anthony M Lowman
Journal:  Tissue Eng Part B Rev       Date:  2011-06-30       Impact factor: 6.389

2.  Time-dependent processes in stem cell-based tissue engineering of articular cartilage.

Authors:  Ivana Gadjanski; Kara Spiller; Gordana Vunjak-Novakovic
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 3.  Clinical translation of controlled protein delivery systems for tissue engineering.

Authors:  Kara L Spiller; Gordana Vunjak-Novakovic
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

4.  Harnessing cell–biomaterial interactions for osteochondral tissue regeneration.

Authors:  Kyobum Kim; Diana M Yoon; Antonios Mikos; F Kurtis Kasper
Journal:  Adv Biochem Eng Biotechnol       Date:  2012       Impact factor: 2.635

5.  Dexamethasone Release from Within Engineered Cartilage as a Chondroprotective Strategy Against Interleukin-1α.

Authors:  Brendan L Roach; Arta Kelmendi-Doko; Elaine C Balutis; Kacey G Marra; Gerard A Ateshian; Clark T Hung
Journal:  Tissue Eng Part A       Date:  2016-03-31       Impact factor: 3.845

6.  Bioactive hydrogels with enhanced initial and sustained cell interactions.

Authors:  Mary Beth Browning; Brooke Russell; Jose Rivera; Magnus Höök; Elizabeth M Cosgriff-Hernandez
Journal:  Biomacromolecules       Date:  2013-06-24       Impact factor: 6.988

7.  Preparation and testing of cefquinome-loaded poly lactic-co-glycolic acid microspheres for lung targeting.

Authors:  Shaoqi Qu; Li Zhao; Jiajia Zhu; Chunmei Wang; Cunchun Dai; Hui Guo; Zhihui Hao
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 8.  Should we use cells, biomaterials, or tissue engineering for cartilage regeneration?

Authors:  Jonathan C Bernhard; Gordana Vunjak-Novakovic
Journal:  Stem Cell Res Ther       Date:  2016-04-18       Impact factor: 6.832

9.  Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.

Authors:  Zongrui Zhang; Xinyu Wang; Binbin Li; Yuanjing Hou; Jing Yang; Li Yi
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

10.  Cell-mediated delivery of glucocorticoids from thiol-ene hydrogels.

Authors:  Chun Yang; Peter D Mariner; Jhenya N Nahreini; Kristi S Anseth
Journal:  J Control Release       Date:  2012-08-11       Impact factor: 9.776

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.